14 Paul Tudor Jones II Moderna Trades
Paul Tudor Jones II acquired 354 Thousand Moderna shares worth $8.63 Million. That's 0.10% of their equity portfolio (223rd largest holding). The first Moderna trade was made in Q3 2020. Since then Paul Tudor Jones II bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $27.9 Million, resulting in a loss of 69%.
News about Moderna Inc and Paul Tudor Jones II
Moderna''s (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
ModernaMRNA announced positive results from the pivotal phase III NextCOVE study evaluating mRNA-1283, its next-generation refrigerator-stable COVID-19 vacci...
Moderna''s Covid-flu combo vaccine come out on top in Phase-III trials
Modernas Covidflu combo vaccine come out on top in PhaseIII trials
Moderna leads development of mRNA vax in infectious diseases: Report
New Delhi, Jan 30: While several pharmaceutical companies have mRNA vaccines in late-stage development for other infectious diseases, Moderna is dominating i...
Moderna, Inc.: MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda , Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melanoma
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of mela...